Efficacy and Speed of Induction of Remission of Infliximab vs Golimumab for Patients With Ulcerative Colitis, Based on Data From Clinical Trials

BACKGROUND & AIMS: With several options available for patients with moderate–severe ulcerative colitis (UC), rapidity of symptom resolution could be an important differentiator. We compared the efficacy and speed of onset of action of infliximab vs golimumab induction therapy using patient-level...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Clin Gastroenterol Hepatol
Main Authors: Singh, Siddharth, Proudfoot, James A., Dulai, Parambir S., Xu, Ronghui, Feagan, Brian G., Sandborn, William J., Jairath, Vipul
Format: Artigo
Sprog:Inglês
Udgivet: 2019
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6858937/
https://ncbi.nlm.nih.gov/pubmed/31108227
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cgh.2019.05.019
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker